Source: International Journal of Impotence Research. Unidade: ICB
Assunto: FARMACOLOGIA
ABNT
SILVA, F. H. da et al. Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide - cyclic GMP pathway in mice. International Journal of Impotence Research, v. 25, n. 2, p. 69-73, 2012Tradução . . Disponível em: https://doi.org/10.1038/ijir.2012.35. Acesso em: 04 nov. 2024.APA
Silva, F. H. da, Pereira, M. N., Franco-Penteado, C. F., De Nucci, G., Antunes, E., & Claudino, M. A. (2012). Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide - cyclic GMP pathway in mice. International Journal of Impotence Research, 25( 2), 69-73. doi:10.1038/ijir.2012.35NLM
Silva FH da, Pereira MN, Franco-Penteado CF, De Nucci G, Antunes E, Claudino MA. Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide - cyclic GMP pathway in mice [Internet]. International Journal of Impotence Research. 2012 ; 25( 2): 69-73.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/ijir.2012.35Vancouver
Silva FH da, Pereira MN, Franco-Penteado CF, De Nucci G, Antunes E, Claudino MA. Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide - cyclic GMP pathway in mice [Internet]. International Journal of Impotence Research. 2012 ; 25( 2): 69-73.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/ijir.2012.35